BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Torphy RJ, Fujiwara Y, Schulick RD. Pancreatic cancer treatment: better, but a long way to go. Surg Today 2020;50:1117-25. [PMID: 32474642 DOI: 10.1007/s00595-020-02028-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu G, Ma Y, Chen Y, Zhuang Y, Yang Y, Tian X. Effects of parecoxib after pancreaticoduodenectomy: A single center randomized controlled trial. Int J Surg 2021;90:105962. [PMID: 33932589 DOI: 10.1016/j.ijsu.2021.105962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hu J, Zheng Z, Lei J, Cao Y, Li Q, Zheng Z, Chen C. Targeting the EZH2-PPAR Axis Is a Potential Therapeutic Pathway for Pancreatic Cancer. PPAR Res 2021;2021:5589342. [PMID: 34335707 DOI: 10.1155/2021/5589342] [Reference Citation Analysis]
3 Kokumai T, Aoki S, Mizuma M, Maeda S, Ohtsuka H, Nakagawa K, Morikawa T, Motoi F, Kamei T, Unno M. Prognostic value of an inflammation-based nutritional score for patients with initially unresectable pancreatic adenocarcinoma undergoing conversion surgery following chemo-/radiotherapy. Surg Today 2021. [PMID: 33829334 DOI: 10.1007/s00595-021-02279-5] [Reference Citation Analysis]
4 Omi K, Matsuo Y, Ueda G, Aoyama Y, Kato T, Hayashi Y, Imafuji H, Saito K, Tsuboi K, Morimoto M, Ogawa R, Takahashi H, Takiguchi S. Escin inhibits angiogenesis by suppressing interleukin‑8 and vascular endothelial growth factor production by blocking nuclear factor‑κB activation in pancreatic cancer cell lines. Oncol Rep 2021;45:55. [PMID: 33760162 DOI: 10.3892/or.2021.8006] [Reference Citation Analysis]
5 Betriu N, Bertran-Mas J, Andreeva A, Semino CE. Syndecans and Pancreatic Ductal Adenocarcinoma. Biomolecules 2021;11:349. [PMID: 33669066 DOI: 10.3390/biom11030349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]